[1] RUXTON C H S, KAJITA C, ROCCA P, et al.Microbiota and probiotics:Chances and challenges-a symposium report[J].Gut Microbiome, 2023, 4:e6.
[2] ANDERSON B D, BISANZ J E.Challenges and opportunities of strain diversity in gut microbiome research[J].Frontiers in Microbiology, 2023, 14:1117122.
[3] VANDEPUTTE D, DE COMMER L, TITO R Y, et al.Temporal variability in quantitative human gut microbiome profiles and implications for clinical research[J].Nature Communications, 2021, 12:6740.
[4] VAN LEEUWEN P T, BRUL S, ZHANG J B, et al.Synthetic microbial communities (SynComs) of the human gut:Design, assembly, and applications[J].FEMS Microbiology Reviews, 2023, 47(2):fuad012.
[5] YADEGAR A, BAR-YOSEPH H, MONAGHAN T M, et al.Fecal microbiota transplantation:Current challenges and future landscapes[J].Clinical Microbiology Reviews, 2024, 37(2):e0006-e00022.
[6] FOLEY M H, MCMILLAN A S, O′FLAHERTY S, et al.Differential modulation of post-antibiotic colonization resistance to Clostridioides difficile by two probiotic Lactobacillus strains[J].mBio, 2025, 16(8):e01468-e01425.
[7] 张娇, 陈江峰, 陈奕璇, 等.合成功能菌群的构建及其工程化应用[J].生物工程学报, 2023,39(6):2517-2545.
ZHANG J, CHEN J F, CHEN Y X, et al.Engineering microbial consortia through synthetic biology approach[J].Chinese Journal of Biotechnology, 2023, 39(6):2517-2545.
[8] JING J Y, GARBEVA P, RAAIJMAKERS J M, et al.Strategies for tailoring functional microbial synthetic communities[J].The ISME Journal, 2024, 18:wrae049.
[9] WU L, WANG X W, TAO Z N, et al.Data-driven prediction of colonization outcomes for complex microbial communities[J].Nature Communications,2024,15:2406.
[10] TANOUE T, MORITA S, PLICHTA D R, et al.A defined commensal consortium elicits CD8 T cells and anti-cancer immunity[J].Nature, 2019, 565(7741):600-605.
[11] CHEN G J, PENG Y J, HUANG Y J, et al.Fluoride induced leaky gut and bloom of Erysipelatoclostridium ramosum mediate the exacerbation of obesity in high-fat-diet fed mice[J].Journal of Advanced Research, 2023, 50:35-54.
[12] WYLENSEK D.Microbial ecology and bile acid conversion within the pig intestine in colon carcinogenesis[D].Aachen:RWTH Aachen University, 2022.
[13] COMOLLI J, WALSH D I, BOBROW J, et al.An in vitro platform for study of the human gut microbiome under an oxygen gradient[J].Biomedical Microdevices, 2023, 25(2):14.
[14] CERQUEIRA F M.Biochemical features of resistant starch degradation by Ruminococcus bromii[D].Ann Arbor:University of Michigan, 2022.
[15] ZHOU Z K, YANG M Y, FANG H, et al.Tailoring a functional synthetic microbial community alleviates Fusobacterium nucleatum-infected colorectal cancer via ecological control[J].Advanced Science, 2025, 12(31):e14232.
[16] VAN DER LELIE D, OKA A, TAGHAVI S, et al.Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis[J].Nature Communications, 2021, 12:3105.
[17] CHENG A G, HO P Y, JAIN S, et al.In vivo augmentation of a complex gut bacterial community[J].bioRxiv, 2021.https://doi.org/10.1101/2021.06.15.44 8620
[18] ATARASHI K, TANOUE T, SHIMA T, et al.Induction of colonie regulatory T cells by indigenous Clostridium species[J].Science, 2011, 331(6015):337-341.
[19] FURUICHI M, KAWAGUCHI T, PUST M M, et al.Commensal consortia decolonize Enterobacteriaceae via ecological control[J].Nature, 2024, 633(8031):878-886.
[20] GNANASEKARAN T, SARATHI A, FANG Q, et al.Quantitative differences in synthetic gut microbial inoculums do not affect the final stabilized in vitro community compositions[J].mSystems, 2023:e01249-e01222.
[21] CHEN H, JIAO J H, WEI M, et al.Metagenomic analysis of the interaction between the gut microbiota and colorectal cancer:A paired-sample study based on the GMrepo database[J].Gut Pathogens, 2022, 14(1):48.
[22] KROPOCHEV A I, LASHIN S A, MATUSHKIN Y G, et al.Trait-based method of quantitative assessment of ecological functional groups in the human intestinal microbiome[J].Biology, 2023, 12(1):115.
[23] BELCOUR A, FRIOUX C, AITE M, et al.Metage2Metabo, microbiota-scale metabolic complementarity for the identification of key species[J].eLife, 2020, 9:e61968.
[24] WUYTS S, ALVES R, ZIMMERMANN-KOGADEEVA M, et al.Consistency across multi-omics layers in a drug-perturbed gut microbial community[J].Molecular Systems Biology, 2023, 19(9):MSB202311525.
[25] CLARK R L, CONNORS B M, STEVENSON D M, et al.Design of synthetic human gut microbiome assembly and butyrate production[J].Nature Communications, 2021, 12:3254.
[26] YANG Q, XIANG W, KHAN A, et al.Programmable probiotic consortium employ an oleic acid-inducible system to sense and degrade cholesterol in high-fat diet mice[J].Gut Microbes, 2025, 17(1):2531198.
[27] LEE D, MUIR P, LUNDBERG S, et al.A CRISPR-Cas9 system protecting E.coli against acquisition of antibiotic resistance genes[J].Scientific Reports, 2025, 15:1545.
[28] WU S B, XUE Y T, YANG S J, et al.Combinational quorum sensing devices for dynamic control in cross-feeding cocultivation[J].Metabolic Engineering, 2021, 67:186-197.
[29] LEE J, MENON N, LIM C T.Dissecting gut-microbial community interactions using a gut microbiome-on-a-chip[J].Advanced Science, 2024, 11(20):2302113.
[30] CHUA M, COLLINS J.Mice colonized with the defined microbial community OMM19.1 are susceptible to Clostridioides difficile infection without prior antibiotic treatment[J].mSphere, 2024, 9(11):e00718-e00724.
[31] STANFORD A H, GONG H Y, NOONAN M, et al.A direct comparison of mouse and human intestinal development using epithelial gene expression patterns[J].Pediatric Research, 2020, 88(1):66-76.
[32] HITCH T C, BOSCH J, BOLSEGA S, et al.Function-based selection of synthetic communities enables mechanistic microbiome studies[J].The ISME journal, 2025, 19(1):wraf209.
[33] EBERL C, RING D, MÜNCH P C, et al.Reproducible colonization of germ-free mice with the oligo-mouse-microbiota in different animal facilities[J].Frontiers in Microbiology, 2020, 10:2999.
[34] QIAO S S, WANG T, SUN J Z, et al.Cross-feeding-based rational design of a probiotic combination of Bacterides xylanisolvens and Clostridium butyricum therapy for metabolic diseases[J].Gut Microbes, 2025, 17(1):2489765.
[35] CHEN X Z, GAO M X, WANG L N, et al.A synthetic microbial consortium protects against obesity by regulating vitamin B6 metabolism[J].Gut Microbes, 2024, 16(1):2304901.
[36] AMBAT A, ANTONY L, MAJI A, et al.Enhancing recovery from gut microbiome dysbiosis and alleviating DSS-induced colitis in mice with a consortium of rare short-chain fatty acid-producing bacteria[J].Gut Microbes, 2024, 16(1):2382324.
[37] DARNAUD M, DE VADDER F, BOGEAT P, et al.A standardized gnotobiotic mouse model harboring a minimal 15-member mouse gut microbiota recapitulates SOPF/SPF phenotypes[J].Nature Communications, 2021, 12:6686.
[38] WEISS A S, NIEDERMEIER L S, VON STREMPEL A, et al.Nutritional and host environments determine community ecology and keystone species in a synthetic gut bacterial community[J].Nature Communications, 2023, 14:4780.
[39] WEISS A S, BURRICHTER A G, DURAI RAJ A C, et al.In vitro interaction network of a synthetic gut bacterial community[J].The ISME Journal, 2022, 16(4):1095-1109.
[40] LE BRAS C, RAULT L, JACQUET N, et al.Two human milk-like synthetic bacterial communities displayed contrasted impacts on barrier and immune responses in an intestinal quadricellular model[J].ISME Communications, 2024, 4:ycad019.
[41] SCHREIBER F, VILLEMIN C, SHARPINGTON T, et al.P0059 Mechanistic understanding of MB310:A consortium of gut commensal bacteria for the treatment of Ulcerative Colitis[J].Journal of Crohn’s and Colitis, 2025, 19(Supplement_1):i418.
[42] LOUIE T, GOLAN Y, KHANNA S, et al.VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection:A randomized clinical trial[J].JAMA, 2023, 329(16):1356-1366.
[43] PRIGIGALLO M I, GÓMEZ-LAMA CABANÁS C, MERCADO-BLANCO J, et al.Designing a synthetic microbial community devoted to biological control:The case study of Fusarium wilt of banana[J].Frontiers in Microbiology, 2022, 13:967885.
[44] DONG S S, ZENG B H, HU L, et al.Effect of a humanized diet profile on colonization efficiency and gut microbial diversity in human flora-associated mice[J].Frontiers in Nutrition, 2021, 8:633738.
[45] AFRIZAL A, JENNINGS S A V, HITCH T C A, et al.Enhanced cultured diversity of the mouse gut microbiota enables custom-made synthetic communities[J].Cell Host & Microbe, 2022, 30(11):1630-1645.e25.
[46] CORDAILLAT-SIMMONS M, ROUANET A, POT B.Live biotherapeutic products:The importance of a defined regulatory framework[J].Experimental & Molecular Medicine, 2020, 52(9):1397-1406.
[47] NORTHEN T R, KLEINER M, TORRES M, et al.Community standards and future opportunities for synthetic communities in plant-microbiota research[J].Nature Microbiology, 2024, 9(11):2774-2784.
[48] PRIYA S, BURNS M B, WARD T, et al.Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration[J].Nature Microbiology, 2022, 7(6):780-795.
[49] SPACOVA I, BINDA S, TER HAAR J A, et al.Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics[J].Frontiers in Microbiology, 2023, 14:1272754.
[50] FRANCIOSA G, GUIDA S, GOMEZ MIGUEL M J, et al.Live biotherapeutic products and their regulatory framework in Italy and Europe[J].Annali Dellistituto Superiore Di Sanità, 2023, 59(1):56-67.
